You just read:

Medac Pharma, Inc. Secures FDA Approval of Trade Name Rasuvo™ for Lead Methotrexate Subcutaneous Injectable Product

News provided by

Medac Pharma, Inc.

Apr 15, 2014, 10:17 ET